Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (125 total)
-
Autor: Nextstrain
Tema: General
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-01-19
Descripción: Nextstrain is an open-source project to harness the scientific and public health potential of pathogen genome data. Datasets are available on ebola, flu, enterovirus, WNV, tb, lassa, mumps, zikka, dengue, ncov, and measles.Genomic epidemiology of… -
Autor: Nextstrain
Tema: General
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-01-11
Descripción: Nextstrain is an open-source project to harness the scientific and public health potential of pathogen genome data. Datasets are available on ebola, flu, enterovirus, WNV, tb, lassa, mumps, zikka, dengue, ncov, and measles.Genetic diversity of… -
Autor: Society of Critical Care Medicine (SCCM)
Tema: General
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-03-27
Descripción: The Society of Critical Care Medicine (SCCM) is rapidly developing and deploying resources to respond to coronavirus disease 2019 (COVID-19). This page includes COVID-19 Response Resources and Guidelines. -
Autor: American Association of Critical Care Nurses (AACN)
Tema: General
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-03-24
Descripción: This page provides COVID-19 resources for nurses including AACN Clinical Resources and Advocacy. -
Autor: University of Nebraska Medical Center / Nebraska Medicine
Tema: General
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-04
Descripción: UNMC Coronavirus (COVID-19) Resources Page -
Autor: ASPR TRACIE
Tema: General
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-04-27
Descripción: This page highlights resources identified or developed to address current response and recovery operations to novel coronavirus 2019 (COVID-19).